申请人:KANDULA Mahesh
公开号:US20150152060A1
公开(公告)日:2015-06-04
The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of migraine and neurologic diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of epilepsy, migraine, Post Herpetic Neuralgia, Acute and Chronic Pain, Alzheimer's disease, Creutzfeld Disease, familial amyloid polyneuropathy, parkinson's disease, fibromyalgia syndrome.
本发明涉及公式I化合物或其药学上可接受的盐,以及其多晶形态、溶剂化物、对映体、立体异构体和水合物。该药物组合物包括有效量的公式I化合物,并可制成口服、颊下、直肠、局部、经皮、经黏膜、静脉、肌肉注射、糖浆或注射剂的药物制剂。这样的组合物可以用于治疗癫痫、偏头痛、带状疱疹后神经痛、急性和慢性疼痛、阿尔茨海默病、克氏肌萎缩症、家族性淀粉样多神经病、帕金森病、纤维肌痛综合征等神经系统疾病的治疗。